|
| 32164883 | Acute Coronary Syndromes and the Nontarget Lesion. | J Am Coll Cardiol | 2020 |
| 27515100 | Long-term prognostic value of risk scores after drug-eluting stent implantation for unprotected left main coronary artery: A pooled analysis of the ISAR-LEFT-MAIN and ISAR-LEFT-MAIN 2 randomized clinical trials. | Catheter Cardiovasc Interv | 2017 |
| 28481954 | Minor defects of the luminal integrity in arterial introducer eSheaths after transcatheter aortic valve implantation. | PLoS One | 2017 |
| 26689707 | Three-year efficacy and safety of new- versus early-generation drug-eluting stents for unprotected left main coronary artery disease insights from the ISAR-LEFT MAIN and ISAR-LEFT MAIN 2 trials. | Clin Res Cardiol | 2016 |
| 24808417 | "First-in-man" MitraClip via pulmonary vein access through a right mini-thoracotomy in a patient with agenesis of the inferior vena cava. | EuroIntervention | 2015 |
| 26603990 | Intraprocedural reduction of the veno-arterial norepinephrine gradient correlates with blood pressure response after renal denervation. | EuroIntervention | 2015 |
| 26435876 | Single Center Retrospective Analysis of Conventional and Radial TIG Catheters for Transradial Diagnostic Coronary Angiography. | Cardiol Res Pract | 2015 |
| 26000297 | Changes of the eSheath Outer Dimensions Used for Transfemoral Transcatheter Aortic Valve Replacement. | Biomed Res Int | 2015 |
| 25976448 | The impact of therapeutic hypothermia on on-treatment platelet reactivity and clinical outcome in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction: Results from the ISAR-SHOCK registry. | Thromb Res | 2015 |
| 25616646 | ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting. | Eur Heart J | 2015 |
| 25244641 | How should I treat dislocation of a TAVI SAPIEN prosthesis into the left ventricle? | EuroIntervention | 2015 |
| 24167092 | Novel mitral clipping technique overcoming extreme atrial dilatation. | Catheter Cardiovasc Interv | 2014 |
| 25610662 | Entanglement due to Delayed Removal of a Buddy Wire. | Case Rep Cardiol | 2014 |
| 25317649 | [Cardiovascular screening for recreational, leisure, vigorous and competitive sport activities over 35 years]. | Dtsch Med Wochenschr | 2014 |
| 25169171 | Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. | J Am Coll Cardiol | 2014 |
| 25132960 | Exercise-induced arterial hypertension - an independent factor for hypertrophy and a ticking clock for cardiac fatigue or atrial fibrillation in athletes? | F1000Res | 2014 |
| 25183544 | Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry. | Thromb Haemost | 2014 |
| 24778122 | Coronary aneurysm with stent dislocation leading to the diagnosis of Marfan syndrome. | Circulation | 2014 |
| 24332416 | Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease. | JACC Cardiovasc Interv | 2014 |
| 23352095 | Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography. | Cardiovasc Revasc Med | 2013 |
| 23973699 | Zotarolimus- versus everolimus-eluting stents for unprotected left main coronary artery disease. | J Am Coll Cardiol | 2013 |
| 23206837 | Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. | Lancet | 2013 |
| 20824758 | Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients. | Catheter Cardiovasc Interv | 2011 |
| 21872918 | Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial. | Lancet | 2011 |
| 21729325 | High sensitive troponin T and heart fatty acid binding protein: novel biomarker in heart failure with normal ejection fraction? A cross-sectional study. | BMC Cardiovasc Disord | 2011 |
| 21384174 | Influence of abciximab on evolution of left ventricular function in patients with non-ST-segment elevation acute coronary syndromes undergoing PCI after clopidogrel pretreatment: lessons from the ISAR-REACT 2 trial. | Clin Res Cardiol | 2011 |
| 21400652 | Angiographic outcomes with biodegradable polymer and permanent polymer drug-eluting stents. | Catheter Cardiovasc Interv | 2011 |
| 20102878 | Quantitative impact of cardiovascular risk factors and vascular closure devices on the femoral artery after repeat cardiac catheterization. | Am Heart J | 2010 |
| 20826260 | Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events. | Am Heart J | 2010 |
| 20859844 | [Recanalization of chronic total coronary occlusion: indications and results]. | Dtsch Med Wochenschr | 2010 |
| 21029815 | Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. | Am J Cardiol | 2010 |
| 20488311 | 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. | J Am Coll Cardiol | 2010 |
| 20486833 | Pharmacological prevention and management of restenosis. | Expert Opin Pharmacother | 2010 |
| 20609310 | Myocardial perfusion grade, myocardial salvage indices and long-term mortality in patients with acute myocardial infarction and full restoration of epicardial blood flow after primary percutaneous coronary intervention. | Rev Esp Cardiol | 2010 |
| 20226618 | Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. | J Am Coll Cardiol | 2010 |
| 20221617 | Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials. | Clin Res Cardiol | 2010 |
| 20118156 | Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction. | Circ Cardiovasc Interv | 2010 |
| 20417052 | 2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents. | J Am Coll Cardiol | 2010 |
| 18758183 | P27 and P53 gene polymorphisms and restenosis following coronary implantation of drug-eluting stents. | Cardiology | 2009 |
| 19926059 | No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents. | JACC Cardiovasc Interv | 2009 |
| 19592388 | Randomised trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis: 2-year follow-up results. | Heart | 2009 |
| 19327417 | A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. | Am J Cardiol | 2009 |
| 19026298 | Risk predictors of retroperitoneal hemorrhage following percutaneous coronary intervention. | Am J Cardiol | 2008 |
| 19006244 | High-frequency vibration for the recanalization of guidewire refractory chronic total coronary occlusions. | Catheter Cardiovasc Interv | 2008 |
| 17400606 | Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting. | Eur Heart J | 2007 |
| 16115485 | Interferon-gamma and interferon-gamma receptor 1 and 2 gene polymorphisms and restenosis following coronary stenting. | Atherosclerosis | 2005 |
| 14572794 | Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting. | Cytokine | 2003 |
| 11907082 | Intracellular domains of target antigens influence their capacity to trigger antibody-dependent cell-mediated cytotoxicity. | J Immunol | 2002 |